The Valley Desk

NCT02234323 · Interventional trial

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Overall registry status Completed

Phase 3

Conditions Hemophilia A

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov